gpt-4o-mini
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.
{
  "first_pass": {
    "id": "chatcmpl-7f116321-76fd-4619-ae79-220579187699",
    "choices": [
      {
        "finish_reason": "stop",
        "index": 0,
        "logprobs": null,
        "message": {
          "content": "The Philippines adheres to the ASEAN (Association of Southeast Asian Nations) guidelines for pharmaceutical stability studies, which align with the International Council for Harmonisation (ICH) Q1D guidelines on bracketing and matrixing designs. These guidelines permit the use of bracketing and matrixing in stability testing under specific conditions.\n\n**Bracketing** involves testing only the extreme values of certain factors, such as strength, container size, or fill volume, assuming that the stability of intermediate levels is represented by the extremes tested. For example, if a product is available in three strengths (e.g., 50 mg, 75 mg, and 100 mg), bracketing would involve testing only the 50 mg and 100 mg strengths, with the assumption that the 75 mg strength's stability is similar to the extremes. ([paperzz.com](https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai))\n\n**Matrixing** is a design where a selected subset of the total number of possible samples for all factor combinations is tested at specific time points. At subsequent time points, another subset is tested, assuming that the stability of each subset represents the stability of all samples at a given time point. ([ema.europa.eu](https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline?utm_source=openai))\n\nThe ASEAN guidelines state that reduced designs, including bracketing and matrixing, can be applied to the stability study of most types of drug products. However, additional justification is required for complex drug delivery systems with numerous potential drug-device interactions. ([paperzz.com](https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai))\n\nTherefore, in the Philippines, the use of bracketing and matrixing study designs in pharmaceutical product stability testing is permitted, provided that the specific conditions outlined in the ASEAN and ICH guidelines are met, and appropriate scientific justification is provided, especially for complex drug delivery systems. ",
          "refusal": null,
          "role": "assistant",
          "annotations": [
            {
              "type": "url_citation",
              "url_citation": {
                "end_index": 926,
                "start_index": 817,
                "title": "ASEAN guideline on stability study of drug",
                "url": "https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai"
              }
            },
            {
              "type": "url_citation",
              "url_citation": {
                "end_index": 1411,
                "start_index": 1240,
                "title": "ICH Q1D Bracketing and matrixing designs for stability testing of drug substances and drug products - Scientific guideline | European Medicines Agency (EMA)",
                "url": "https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline?utm_source=openai"
              }
            },
            {
              "type": "url_citation",
              "url_citation": {
                "end_index": 1807,
                "start_index": 1698,
                "title": "ASEAN guideline on stability study of drug",
                "url": "https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai"
              }
            }
          ],
          "audio": null,
          "function_call": null,
          "tool_calls": null
        }
      }
    ],
    "created": 1756270088,
    "model": "gpt-4o-mini-search-preview-2025-03-11",
    "object": "chat.completion",
    "service_tier": null,
    "system_fingerprint": "",
    "usage": {
      "completion_tokens": 443,
      "prompt_tokens": 68,
      "total_tokens": 511,
      "completion_tokens_details": {
        "accepted_prediction_tokens": 0,
        "audio_tokens": 0,
        "reasoning_tokens": 0,
        "rejected_prediction_tokens": 0
      },
      "prompt_tokens_details": {
        "audio_tokens": 0,
        "cached_tokens": 0
      }
    }
  },
  "second_pass": {
    "id": "resp_68ae8e0e11a0819594e9079b5267c43f0f44dc8d8783137e",
    "created_at": 1756270094.0,
    "error": null,
    "incomplete_details": null,
    "instructions": null,
    "metadata": {},
    "model": "gpt-4o-mini-2024-07-18",
    "object": "response",
    "output": [
      {
        "id": "msg_68ae8e0eee70819599f0db45aa1ab18b0f44dc8d8783137e",
        "content": [
          {
            "annotations": [],
            "text": "{\"status\":\"YES\",\"explanation\":\"The Philippines allows the use of bracketing and matrixing in pharmaceutical product stability testing, adhering to ASEAN and ICH guidelines, with specific conditions and justifications required for certain complex drug delivery systems.\",\"sources\":[\"https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai\",\"https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline?utm_source=openai\"]}",
            "type": "output_text",
            "logprobs": [],
            "parsed": {
              "status": "YES",
              "explanation": "The Philippines allows the use of bracketing and matrixing in pharmaceutical product stability testing, adhering to ASEAN and ICH guidelines, with specific conditions and justifications required for certain complex drug delivery systems.",
              "sources": [
                "https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai",
                "https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline?utm_source=openai"
              ]
            }
          }
        ],
        "role": "assistant",
        "status": "completed",
        "type": "message"
      }
    ],
    "parallel_tool_calls": true,
    "temperature": 1.0,
    "tool_choice": "auto",
    "tools": [],
    "top_p": 1.0,
    "background": false,
    "conversation": null,
    "max_output_tokens": null,
    "max_tool_calls": null,
    "previous_response_id": null,
    "prompt": null,
    "prompt_cache_key": null,
    "reasoning": {
      "effort": null,
      "generate_summary": null,
      "summary": null
    },
    "safety_identifier": null,
    "service_tier": "default",
    "status": "completed",
    "text": {
      "format": {
        "name": "QueryResponse",
        "schema_": {
          "$defs": {
            "Status": {
              "enum": [
                "YES",
                "NO",
                "PARTIAL",
                "UNKNOWN"
              ],
              "title": "Status",
              "type": "string"
            }
          },
          "properties": {
            "status": {
              "description": "Status of the policy for the given country",
              "enum": [
                "YES",
                "NO",
                "PARTIAL",
                "UNKNOWN"
              ],
              "title": "Status",
              "type": "string"
            },
            "explanation": {
              "description": "1 sentence explanation of the status with citations",
              "title": "Explanation",
              "type": "string"
            },
            "sources": {
              "description": "A list of URLs cited in the explanation",
              "items": {
                "type": "string"
              },
              "title": "Sources",
              "type": "array"
            }
          },
          "required": [
            "status",
            "explanation",
            "sources"
          ],
          "title": "QueryResponse",
          "type": "object",
          "additionalProperties": false
        },
        "type": "json_schema",
        "description": null,
        "strict": true
      },
      "verbosity": "medium"
    },
    "top_logprobs": 0,
    "truncation": "disabled",
    "usage": {
      "input_tokens": 1703,
      "input_tokens_details": {
        "cached_tokens": 0
      },
      "output_tokens": 123,
      "output_tokens_details": {
        "reasoning_tokens": 0
      },
      "total_tokens": 1826
    },
    "user": null,
    "store": true
  }
}